431 related articles for article (PubMed ID: 12189722)
1. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O
Curr Gene Ther; 2002 Sep; 2(3):379-92. PubMed ID: 12189722
[TBL] [Abstract][Full Text] [Related]
2. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
He J; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
[TBL] [Abstract][Full Text] [Related]
3. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
4. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
[TBL] [Abstract][Full Text] [Related]
8. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
Iwai M; Harada Y; Tanaka S; Muramatsu A; Mori T; Kashima K; Imanishi J; Mazda O
Biochem Biophys Res Commun; 2002 Feb; 291(1):48-54. PubMed ID: 11829460
[TBL] [Abstract][Full Text] [Related]
9. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
10. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer.
Maruyama-Tabata H; Harada Y; Matsumura T; Satoh E; Cui F; Iwai M; Kita M; Hibi S; Imanishi J; Sawada T; Mazda O
Gene Ther; 2000 Jan; 7(1):53-60. PubMed ID: 10680016
[TBL] [Abstract][Full Text] [Related]
11. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo.
Nakanishi H; Mazda O; Satoh E; Asada H; Morioka H; Kishida T; Nakao M; Mizutani Y; Kawauchi A; Kita M; Imanishi J; Miki T
Gene Ther; 2003 Mar; 10(5):434-42. PubMed ID: 12601398
[TBL] [Abstract][Full Text] [Related]
12. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
14. Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.
Zuo Y; Wu J; Xu Z; Yang S; Yan H; Tan L; Meng X; Ying X; Liu R; Kang T; Huang W
PLoS One; 2011 May; 6(5):e19407. PubMed ID: 21573215
[TBL] [Abstract][Full Text] [Related]
15. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
[TBL] [Abstract][Full Text] [Related]
16. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells.
Tomiyasu K; Satoh E; Oda Y; Nishizaki K; Kondo M; Imanishi J; Mazda O
Biochem Biophys Res Commun; 1998 Dec; 253(3):733-8. PubMed ID: 9918796
[TBL] [Abstract][Full Text] [Related]
18. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
19. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors.
Howden SE; Wardan H; Voullaire L; McLenachan S; Williamson R; Ioannou P; Vadolas J
Hum Gene Ther; 2006 Aug; 17(8):833-44. PubMed ID: 16942443
[TBL] [Abstract][Full Text] [Related]
20. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
Judde JG; Spangler G; Magrath I; Bhatia K
Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
